Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes

GLIA

Volumn 58, Issue 3, 2010, Pages 344-366

  Sbai, Oualid ^a   Ould Yahoui, Adlane ^a   Ferhat, Lotfi ^a   Gueye, Yatma ^a   Bernard, Anne ^a   Charrat, Eliane ^a   Mehanna, Ali ^a   Risso, Jean Jacques ^b   Chauvin, Jean Paul ^c   Fenouillet, Emmanuel ^a   Rivera, Santiago ^a   Khrestchatisky, Michel ^a  

^a Mediterranée University   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Brain; Cytoskeleton; Gliosis; Inflammation; Mouse; Nucleus; Reactivity; Secretion; Vesicle

Indexed keywords

GELATINASE A; GELATINASE B; KINESIN; MYOSIN V; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL DISRUPTION; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME RELEASE; INFLAMMATION; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL COMPARTMENTATION; CELLS, CULTURED; ENCEPHALITIS; GLIOSIS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOMES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MOLECULAR MOTOR PROTEINS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSPORT VESICLES;

EID: 75849123055     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20927     Document Type: Article

References (91)

1. Abd-El-Basset EM, Fedoroff S. 1997. Upregulation of F-actin and alpha-actinin in reactive astrocytes. J Neurosci Res 49:608-616.
2. Arai K, Lee SR, Lo EH. 2003. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia 43:254-264.
3. Ben-Hur T, Ben-Yosef Y, Mizrachi-Kol R, Ben-Menachem O, Miller A. 2006. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells. J Neuroimmunol 175(1/2):12-18.
4. Buss F, Spudich G, Kendrick-Jones J. 2004. Myosin VI: Cellular functions and motor properties. Annu Rev Cell Dev Biol 20:649-676.
5. Calegari F, Coco S, Taverna E, Bassetti M, Verderio C, Corradi N, Matteoli M, Rosa P. 1999. A regulated secretory pathway in cultured hippocampal astrocytes. J Biol Chem 274:22539-22547.
6. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA. 2005. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120:421-433.
7. Chung IY, Benveniste EN. 1990. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 144:2999-3007.
8. Crippa D, Schenk U, Francolini M, Rosa P, Verderio C, Zonta M, Pozzan T, Matteoli M, Carmignoto G. 2006. Synaptobrevin2-expressing vesicles in rat astrocytes: Insights into molecular characterization, dynamics and exocytosis. J Physiol 570(Pt 3):567-582.
9. Crocker SJ, Frausto RF, Whitton JL, Milner R. 2008. A novel method to establish microglia-free astrocyte cultures: Comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Glia 56:1187-1198.
10. Crocker SJ, Milner R, Pham-Mitchell N, Campbell IL. 2006. Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells. J Neurochem 98:812-823.
11. Cuadrado E, Rosell A, Borrell-Pages M, Garcia-Bonilla L, Hernandez-Guillamon M, Ortega-Aznar A, Montaner J. 2009. Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia. J Cereb Blood Flow Metab 29:398-410.
12. Delbro D, Westerlund A, Bjorklund U, Hansson E. 2009. In inflammatory reactive astrocytes co-cultured with brain endothelial cells nicotine-evoked Ca(2+) transients are attenuated due to interleukin-1beta release and rearrangement of actin filaments. Neuroscience 159:770-779.
13. DePina AS, Langford GM. 1999. Vesicle transport: The role of actin filaments and myosin motors. Microsc Res Tech 47:93-106.
14. Djukic M, Mildner A, Schmidt H, Czesnik D, Bruck W, Priller J, Nau R, Prinz M. 2006. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 129 (Pt 9):2394-2403.
15. Dolo V, Ginestra A, Ghersi G, Nagase H, Vittorelli ML. 1994. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicrosc Cytol Pathol 26:173-180.
16. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
17. Dzwonek J, Rylski M, Kaczmarek L. 2004. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 567:129-135.
18. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174.
19. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24:2143-2155.
20. Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML. 1997. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem 272:17216-17222.
21. Giraudon P, Buart S, Bernard A, Belin MF. 1997. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes. Mol Psychiatry 2:107-110,184.
22. Grafstein B, Forman DS. 1980. Intracellular transport in neurons. Physiol Rev 60:1167-1283.
23. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. 2004. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64:7045-7049.
24. Guillemin G, Boussin FD, Croitoru J, Franck-Duchenne M, Le Grand R, Lazarini F, Dormont D. 1997. Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brains. J Neurosci Res 49:576-591.
25. Hicks GR, Raikhel NV. 1995. Protein import into the nucleus: An integrated view. Annu Rev Cell Dev Biol 11:155-188.
26. Ho WT, Exton JH, Williger BT. 2003. Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells. FEBS Lett 537(1-3):91-95.
27. Howard EW, Bullen EC, Banda MJ. 1991. Preferential inhibition of 72-and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 266:13070-13075.
28. Jaworski DM. 2000. Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury. Glia 30:199-208.
29. Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, Le Diguardher T, Khrestchatisky M, Rivera S. 2003. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 18:1507-1517.
30. Kitchens RL. 2000. Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol 74:61-82.
31. Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R. 2004. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly(ADP-ribose) polymerase (PARP) in vitro. FASEB J 18:690-692.
32. Laird MD, Vender JR, Dhandapani KM. 2008. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16(2/3):154-164.
33. Langford GM. 2002. Myosin-V, a versatile motor for short-range vesicle transport. Traffic 3:859-865.
34. Le NT, Xue M, Castelnoble LA, Jackson CJ. 2007. The dual personalities of matrix metalloproteinases in inflammation. Front Biosci 12:1475-1487.
35. Lee SY, Kim HJ, Lee WJ, Joo SH, Jeon SJ, Kim JW, Kim HS, Han SH, Lee J, Park SH, Cheong JH, Kim WK, Ko KH, Shin CY. 2008. Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharidestimulated rat primary astrocytes. Neurochem Res 33:2324-2334.
36. Lee WJ, Shin CY, Yoo BK, Ryu JR, Choi EY, Cheong JH, Ryu JH, Ko KH. 2003. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide- stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41:15-24.
37. Li D, Ropert N, Koulakoff A, Giaume C, Oheim M. 2008. Lysosomes are the major vesicular compartment undergoing Ca2+-regulated exocytosis from cortical astrocytes. J Neurosci 28:7648-7658.
38. Lippincott-Schwartz J, Fambrough DM. 1987. Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: Kinetic and morphological analysis. Cell 49:669-677.
39. Liu W, Furuichi T, Miyake M, Rosenberg GA, Liu KJ. 2007. Differential expression of tissue inhibitor of metalloproteinases-3 in cultured astrocytes and neurons regulates the activation of matrix metalloproteinase-2. J Neurosci Res 85:829-836.
40. Liuzzi GM, Mastroianni CM, Latronico T, Mengoni F, Fasano A, Lichtner M, Vullo V, Riccio P. 2004. Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia. Brain 127 (Pt 2):398-407.
41. Lopez-Otin C, Matrisian LM. 2007. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7:800-808.
42. Maienschein V, Marxen M, Volknandt W, Zimmermann H. 1999. A plethora of presynaptic proteins associated with ATP-storing organelles in cultured astrocytes. Glia 26:233-244.
43. Monferran S, Paupert J, Dauvillier S, Salles B, Muller C. 2004. The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. EMBO J 23:3758-3768.
44. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH. 2002. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100(1/2):103-117.
45. Nedergaard M, Ransom B, Goldman SA. 2003. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci 26:523-530.
46. Ogier C, Bernard A, Chollet AM, T LED, Hanessian S, Charton G, Khrestchatisky M, Rivera S. 2006. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 54:272-284.
47. Ogier C, Creidy R, Boucraut J, Soloway PD, Khrestchatisky M, Rivera S. 2005. Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. BMC Neurosci 6:68.
48. O'shea RD, Lau CL, Farso MC, Diwakarla S, Zagami CJ, Svendsen BB, Feeney SJ, Callaway JK, Jones NM, Pow DV, Danbolt NC, Jarrott B, Beart PM. 2006. Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: Evidence for delayed up-regulation and redistribution of GLT-1. Neurochem Int 48(6/7):604-610.
49. Page LJ, Darmon AJ, Uellner R, Griffiths GM. 1998. L is for lytic granules: Lysosomes that kill. Biochim Biophys Acta 1401:146-156.
50. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729-741.
51. Pang Y, Cai Z, Rhodes PG. 2001. Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays. Brain Res 914(1/2):15-22.
52. Pekny M, Nilsson M. 2005. Astrocyte activation and reactive gliosis. Glia 50:427-434.
53. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M. 2007. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82:95-111.
54. Phelps MA, Foraker AB, Swaan PW. 2003. Cytoskeletal motors and cargo in membrane trafficking: Opportunities for high specificity in drug intervention. Drug Discov Today 8:494-502.
55. Pilzer D, Gasser O, Moskovich O, Schifferli JA, Fishelson Z. 2005. Emission of membrane vesicles: Roles in complement resistance, immunity and cancer. Springer Semin Immunopathol 27:375-387.
56. Potokar M, Kreft M, Pangrsic T, Zorec R. 2005. Vesicle mobility studied in cultured astrocytes. Biochem Biophys Res Commun 329:678-683.
57. Prekeris R, Terrian DM. 1997. Brain myosin V is a synaptic vesicleassociated motor protein: Evidence for a Ca2+-dependent interaction with the synaptobrevin-synaptophysin complex. J Cell Biol 137:1589-1601.
58. Price B, Dennison C, Tschesche H, Elliott E. 2000. Neutrophil tissue inhibitor of matrix metalloproteinases-1 occurs in novel vesicles that do not fuse with the phagosome. J Biol Chem 275:28308-28315.
59. Rahat MA, Marom B, Bitterman H, Weiss-Cerem L, Kinarty A, Lahat N. 2006. Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J Leukoc Biol 79:706-718.
60. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
61. Rivera S, Khrestchatisky M. 1999. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuronal plasticity and pathology. In: Baudry M, Thomsom RF, Davis JL, editors. Advances in synaptic plasticity. Cambridge, MA: The MIT Press. pp 53-86.
62. Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk AW, Miller K, Gearing AJ, Kaczmarek L, Khrestchatisky M. 2002. Gelatinase B, TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 15:19-32.
63. Rivera S, Tremblay E, Timsit S, Canals O, Ben-Ari Y, Khrestchatisky M. 1997. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: Evidence for developmental, immediate early gene, and lesion response. J Neurosci 17:4223-4235.
64. Rodriguez A, Webster P, Ortego J, Andrews NW. 1997. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 137:93-104.
65. Rosenberg GA. 2002. Matrix metalloproteinases in neuroinflammation. Glia 39:279-291.
66. Sanka K, Maddala R, Epstein DL, Rao PV. 2007. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 48:2105-2114.
67. Sbai O, Ferhat L, Bernard A, Gueye Y, Ould-Yahoui A, Thiolloy S, Charrat E, Charton G, Tremblay E, Risso JJ, Chauvin JP, Arsanto JP, Rivera S, Khrestchatisky M. 2008. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Mol Cell Neurosci 39:549-568.
68. Schnaeker EM, Ossig R, Ludwig T, Dreier R, Oberleithner H, Wilhelmi M, Schneider SW. 2004. Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: Prerequisite in human melanoma cell invasion. Cancer Res 64:8924-8931.
69. Schnyder J, Baggiolini M. 1978. Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages. J Exp Med 148:435-450.
70. Shin CY, Lee WJ, Choi JW, Choi MS, Park GH, Yoo BK, Han SY, Ryu JR, Choi EY, Ko KH. 2007. Role of p38 MAPK on the down-regulation of matrix metalloproteinase-9 expression in rat astrocytes. Arch Pharm Res 30:624-633.
71. Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, Cubel G, Taras D, Blanc JF, Robinson DR, Rosenbaum J. 2006. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169:1390-1401.
72. Sofroniew MV. 2005. Reactive astrocytes in neural repair and protection. Neuroscientist 11:400-407.
73. Spina-Purrello V, Patti D, Giuffrida-Stella AM, Nicoletti VG. 2008. Parp and cell death or protection in rat primary astroglial cell cultures under LPS/IFNgamma induced proinflammatory conditions. Neurochem Res 33:2583-2592.
74. Stachelek SJ, Kowalik TF, Farwell AP, Leonard JL. 2000. Myosin V plays an essential role in the thyroid hormone-dependent endocytosis of type II iodothyronine 50-deiodinase. J Biol Chem 275:31701-31707.
75. Stetler-Stevenson WG, Krutzsch HC, Liotta LA. 1989. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374-17378.
76. Szklarczyk A, Lapinska J, Rylski M, McKay RD, Kaczmarek L. 2002. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 22:920-930.
77. Tapper H, Sundler R. 1990. Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem J 272:407-414.
78. Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A, Dolo V. 2006. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8:96-103.
79. Taraboletti G, Sonzogni L, Vergani V, Hosseini G, Ceruti R, Ghilardi C, Bastone A, Toschi E, Borsotti P, Scanziani E, Giavazzi R, Pepper MS, Stetler-Stevenson WG, Bani MR. 2000. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells. Exp Cell Res 258:384-394.
80. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. 2001. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166:7309-7318.
81. Tu C, Ortega-Cava CF, Chen G, Fernandes ND, Cavallo-Medved D, Sloane BF, Band V, Band H. 2008. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts. Cancer Res 68:9147-9156.
82. Tvarusko W, Bentele M, Misteli T, Rudolf R, Kaether C, Spector DL, Gerdes HH, Eils R. 1999. Time-resolved analysis and visualization of dynamic processes in living cells. Proc Natl Acad Sci USA 96:7950-7955.
83. Unanue ER. 1976. Secretory function of mononuclear phagocytes: A review. Am J Pathol 83:396-418.
84. Vaillant C, Didier-Bazes M, Hutter A, Belin MF, Thomasset N. 1999. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 19:4994-5004.
85. Vittorelli ML. 2003. Shed membrane vesicles and clustering of membrane-bound proteolytic enzymes. Curr Top Dev Biol 54:411-432.
86. Volknandt W. 2002. Vesicular release mechanisms in astrocytic signalling. Neurochem Int 41:301-306.
87. Whiteside TL. 2005. Tumour-derived exosomes or microvesicles: Another mechanism of tumour escape from the host immune system? Br J Cancer 92:209-211.
88. Wilczynska KM, Gopalan SM, Bugno M, Kasza A, Konik BS, Bryan L, Wright S, Griswold-Prenner I, Kordula T. 2006. A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes. J Biol Chem 281:34955-34964.
89. Yong VW. 2005. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6:931-944.
90. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH. 2006. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441-445.
91. Zucker S, Wieman JM, Lysik RM, Wilkie DP, Ramamurthy N, Lane B. 1987. Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles. Biochim Biophys Acta 924:225-237.